Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 12/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.38 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.37 |
| ▸ | MLNR | O43193 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20121576 | 0.93 | KCNH2 (0.78) | KCNH2CYP3A4ALDH1A1GPBAR1MLNR | |
| SCHEMBL17636399 | 0.93 | KCNH2 (0.78) | KCNH2CYP3A4ALDH1A1GPBAR1MLNR | |
| SCHEMBL20121613 | 0.93 | KCNH2 (0.78) | KCNH2CYP3A4ALDH1A1GPBAR1MLNR | |
| SCHEMBL12952020 | 0.90 | KCNH2 (0.77) | KCNH2CYP3A4L3MBTL1MEN1KMT2A | |
| SCHEMBL12952261 | 0.90 | KCNH2 (0.73) | KCNH2CYP3A4ALDH1A1MLNRMEN1 | |
| SCHEMBL12952026 | 0.89 | KCNH2 (0.78) | KCNH2CYP3A4L3MBTL1MEN1KMT2A | |
| SCHEMBL12952031 | 0.89 | KCNH2 (0.68) | KCNH2CYP3A4SMN1; SMN2MLNRMEN1 | |
| SCHEMBL12952248 | 0.89 | KCNH2 (0.75) | KCNH2CYP3A4ALDH1A1GPBAR1MLNR | |
| SCHEMBL15760176 | 0.89 | KCNH2 (0.72) | KCNH2CYP3A4ALDH1A1MLNRMEN1 | |
| SCHEMBL20121603 | 0.89 | KCNH2 (0.78) | KCNH2CYP3A4ALDH1A1GPBAR1MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963454-B2 | Compounds and compositions for the treatment of parasitic disease | NOVARTIS AG (CH) | 2018-05-08 | — | — | US | disclosed |